N. Azarnia
Impact in
- Otorhinolaryngology top 0.1%
- Head and Neck Cancer Studies
- Oncology top 0.5%
- Colorectal Cancer Treatments and Studies
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
Papers in
- Hematology 21
- Acute Myeloid Leukemia Research 20
- Hematopoietic Stem Cell Transplantation 7
- Chronic Myeloid Leukemia Treatments 6
- Oncology 14
- Cancer Treatment and Pharmacology 7
- Co-authors
- Dong M. Shin (4 shared papers)Merrill S. Kies (2 shared papers)Eric K. Rowinsky (3 shared papers)José Baselga (7 shared papers)Paul M. Harari (7 shared papers)James A. Bonner (7 shared papers)J. Giralt (7 shared papers)David Raben (5 shared papers)
- Journals
- Journal of Clinical Oncology (16 papers)International Journal of Radiation Oncology*Biology*Physics (5 papers)Blood (4 papers)British Journal of Haematology (4 papers)European Journal of Cancer (3 papers)
- Partner nations
- United StatesFrancePoland
In The Last Decade
N. Azarnia
52 papers receiving 6.3k citations
N. Azarnia's Hit Papers
Peers
Comparison fields: 5 of 111
- Otorhinolaryngology 1.8k
- Oncology 2.6k
- Pulmonary and Respiratory Medicine 1.8k
- Hematology 380
- Cancer Research 425
Countries citing papers authored by N. Azarnia
This map shows the geographic impact of N. Azarnia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N. Azarnia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N. Azarnia more than expected).
Fields of papers citing papers by N. Azarnia
This network shows the impact of papers produced by N. Azarnia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N. Azarnia. The network helps show where N. Azarnia may publish in the future.
Co-authors
The 25 scholars most cited alongside N. Azarnia, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 52 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck Hit paper breakdown → | 2006 | 3729 |
| 2 | 2006 | 419 | |
| 3 | 2001 | 391 | |
| 4 | 1990 | 368 | |
| 5 | 2005 | 300 | |
| 6 | 2004 | 163 | |
| 7 | 2004 | 115 | |
| 8 | 2004 | 80 | |
| 9 | 2006 | 78 | |
| 10 | 2014 | 76 | |
| 11 | 1991 | 69 | |
| 12 | 1987 | 68 | |
| 13 | 1999 | 67 | |
| 14 | 1987 | 67 | |
| 15 | 1984 | 53 | |
| 16 | 1999 | 51 | |
| 17 | 1986 | 39 | |
| 18 | 1993 | 38 | |
| 19 | 2004 | 35 | |
| 20 | 1986 | 34 |
About N. Azarnia
N. Azarnia is a scholar working on Hematology, Oncology, Pulmonary and Respiratory Medicine, Public Health, Environmental and Occupational Health and Genetics, having authored 52 papers that have together received 6.5k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (20 papers), Acute Lymphoblastic Leukemia research (13 papers), Lung Cancer Treatments and Mutations (11 papers), Chronic Lymphocytic Leukemia Research (10 papers), Head and Neck Cancer Studies (8 papers), Cancer Treatment and Pharmacology (7 papers), Hematopoietic Stem Cell Transplantation (7 papers) and Chronic Myeloid Leukemia Treatments (6 papers). The work is most often cited by research in Otorhinolaryngology (1.8k citations), Oncology (2.6k citations), Pulmonary and Respiratory Medicine (1.8k citations), Hematology (380 citations) and Cancer Research (425 citations). N. Azarnia has collaborated with scholars based in United States, France and Poland. Frequent co-authors include Dong M. Shin, Merrill S. Kies, Eric K. Rowinsky, José Baselga, Paul M. Harari, James A. Bonner, J. Giralt, David Raben, Christopher U. Jones and Jacek Jassem. Their work appears in journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics, Blood, British Journal of Haematology and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.